MiMedx (MDXG) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

MiMedx Group Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results.
Benzinga14:42 ET
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga12:34 ET
Cantor Fitzgerald Maintains MiMedx(MDXG.US) With Buy Rating, Maintains Target Price $11
Moomoo NewsOct 31 07:34 ET · Ratings
MiMedx Group, Inc. (MDXG) Q3 2024 Earnings Call Transcript
Earnings Call TranscriptsOct 30 21:38 ET
Earnings Flash (MDXG) MIMEDX GROUP Posts Q3 EPS $0.07
MT NewswiresOct 30 16:36 ET
MiMedx: Q3 Earnings Snapshot
Yahoo FinanceOct 30 16:26 ET

Comments

Stock Region

Mar 4 11:39

Investment Firm Raises Price Target For Major Biotech Company

Mizuho Boosts MiMedx Group's Price Target to $14, Continues Bullish Outlook.
In a recent move that underscores their confidence in the regenerative medicine sector, Mizuho Securities has maintained its 'Buy' rating on MiMedx Group Inc. (NASDAQ: MDXG) and has raised the price target from a previous estimate to $14. This comes as the company continues to make significant strides in its advanced wound care and surgical tissue solutions. $MiMedx (MDXG.US)$
...

Moomoo AI

Mar 4 07:13

MIMEDX's Chair and CEO have expressed optimism about the new appointments, stating that Olson and Puhy will contribute to the company's strategic vision and provide valuable insights. Their skills and leadership records will elevate the Board.

Press Release: MIMEDX Announces Appointment of Two New Independent Directors

Moomoo AI

Jan 22 07:15

CFO Doug Rice asserts the new debt facility offers more flexibility for long-term strategic goals. The terms mirror the company's progress in enhancing its financial profile and reducing interest expense.

Press Release: MIMEDX Announces Improved Capital Structure With New Senior Secured Credit Facilities and Debt Refinancing

Moomoo AI

Dec 21, 2023 01:30

Analysts say that MiMedx's low projected revenue growth may contribute to its weak P/S ratio. Significant performance improvements would be needed for a potential P/S ratio rise. The low P/S ratio casts doubt on the company's potential despite its share price increase.

MiMedx Group, Inc. (NASDAQ:MDXG) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

1

Moomoo AI

Dec 19, 2023 07:09

Carlson's experience could potentially elevate Spectral AI's position in the market. The potential impact of its breakthrough technology could present substantial opportunities for growth and value in the healthcare industry.

Press Release: Spectral AI Names Industry Veteran and Former Top MiMedx Financial Executive Peter M. Carlson as CFO

MDXG MiMedx

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target